Surface plasmon resonance sensing: from purified biomolecules to intact cells
Surface plasmon resonance (SPR) has become a well-recognized label-free technique for measuring the binding kinetics between biomolecules since the invention of the first SPR-based immunosensor in 1980s. The most popular and traditional format for SPR analysis is to monitor the real-time optical signals when a solution containing ligand molecules is flowing over a sensor substrate functionalized with purified receptor molecules. In recent years, rapid development of several kinds of SPR imaging techniques have allowed for mapping the dynamic distribution of local mass density within single living cells with high spatial and temporal resolutions and reliable sensitivity. Such capability immediately enabled one to investigate the interaction between important biomolecules and intact cells in a label-free, quantitative, and single cell manner, leading to an exciting new trend of cell-based SPR bioanalysis. In this Trend Article, we first describe the principle and technical features of two types of SPR imaging techniques based on prism and objective, respectively. Then we survey the intact cell-based applications in both fundamental cell biology and drug discovery. We conclude the article with comments and perspectives on the future developments.
KeywordsSurface plasmon resonance (SPR) Biosensor Label-free Cell biology Drug discovery
The authors acknowledge financial support from the National Natural Science Foundation of China (21522503), the Natural Science Foundation of Jiangsu Province (BK20150013), and the Science and Technology Fund of Nanjing Medical University (2014NJMUZD018).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 3.Homola J (2008) Surface plasmon resonance sensors for detection of chemical and biological species. Chem Rev 108(2):462–493Google Scholar
- 4.Phillips KS, Cheng Q (2007) Recent advances in surface plasmon resonance based techniques for bioanalysis. Anal Bioanal Chem 387(5):1831–1840Google Scholar
- 15.Meneghello A, Tartaggia S, Alvau MD, Polo F, Toffoli G. Biosensing technologies for therapeutic drug monitoring. Curr Med Chem. 2017.Google Scholar
- 18.Wang S, Shan X, Patel U, Huang X, Lu J, Li J. (2010) Label-free imaging, detection, and mass measurement of single viruses by surface plasmon resonance. Proc Natl Acad Sci U S A. 107(37):16028–32.Google Scholar
- 27.Chabot V, Miron Y, Charette PG, Grandbois M. Identification of the molecular mechanisms in cellular processes that elicit a surface plasmon resonance (SPR) response using simultaneous surface plasmon-enhanced fluorescence (SPEF) microscopy. Biosens Bioelectron. 2013;50:125–31.CrossRefPubMedGoogle Scholar
- 39.Yanase Y, Araki A, Suzuki H, Tsutsui T, Kimura T, Okamoto K. (2010) Development of an optical fiber SPR sensor for living cell activation. Biosens Bioelectron. 25(5):1244–7.Google Scholar
- 40.Peungthum P, Sudprasert K, Amarit R, Somboonkaew A, Sutapun B, Vongsakulyanon A. (2017) Surface plasmon resonance imaging for ABH antigen detection on red blood cells and in saliva: secretor status-related ABO subgroup identification. Analyst. 142(9):1471–81.Google Scholar
- 46.Berthuy OI, Blum LJ, Marquette CA. Cancer cells on chip for label-free detection of secreted molecules. Biosensors (Basel). 2016;6(1).Google Scholar
- 49.Bech EM, Martos-Maldonado MC, Wismann P, Sorensen KK, van Witteloostuijn SB, Thygesen MB. Peptide half-life extension: divalent, small-molecule albumin interactions direct the systemic properties of glucagon-like peptide 1 (GLP-1) analogues. J Med Chem. 2017;60(17):7434–46.CrossRefPubMedGoogle Scholar
- 51.Bresciani A, Missineo A, Gallo M, Cerretani M, Fezzardi P, Tomei L. Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1). Arch Biochem Biophys. 2017;631:31–41.CrossRefPubMedGoogle Scholar
- 53.Donnelly DJ, Smith RA, Morin P, Lipovsek D, Gokemeijer J, Cohen D. Synthesis and biological evaluation of a novel 18F-labeled adnectin as a PET radioligand for imaging PD-L1 expression. J Nucl Med. 2017.Google Scholar